Tempus AI Prepares for Earnings Announcement Amid Analyst Upgrades

Author: Dylan Bailey Updated: 08-08-2025 02:42 AM

Tempus AI's Upcoming Earnings Report

Tempus AI, Inc. (NASDAQ: TEM) is gearing up to unveil its earnings report for the second quarter shortly. This report is highly anticipated, with analysts closely monitoring what the company will announce.

Expectations from Analysts

The market is buzzing with expectations that the Chicago-based company will report a quarterly loss of around 25 cents per share. This marks a significant improvement when compared to a loss of 63 cents per share from the same period last year. Analysts project that Tempus AI will achieve quarterly revenues around $297.76 million, a substantial increase from the $165.97 million reported a year ago.

Significant Regulatory Milestone

In a noteworthy achievement, Tempus AI disclosed on July 16 that it had secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative ejection fraction software. This approval is expected to enhance the company’s offerings and market position.

Stock Performance

Recent trading data indicates that Tempus AI shares surged by 5.8%, closing at $58.74. This rise can be attributed to the positive sentiment surrounding upcoming earnings and recent analyst upgrades.

Firm Ratings and Price Targets

A host of analysts have shared their insights on Tempus AI's stock:

Piper Sandler's David Westenberg has maintained a Neutral rating while raising the price target from $55 to $70.
Needham analyst Ryan MacDonald reiterated a Buy rating, setting a price target of $70.
BTIG’s Mark Massaro began coverage with a Buy rating, targeting a price of $60.
JP Morgan’s Rachel Vatnsdal adjusted the rating from Overweight to Neutral, increasing the price target from $50 to $55.
TD Cowen’s Dan Brennan reinstated a Buy rating, increasing the target to $74.

As discussions around these price adjustments heat up, investors looking at TEM may find it prudent to consider the opinions of these analysts.

Interest in TEM Stock

For potential investors curious about TEM stock, understanding these analyst perspectives is crucial as they offer valuable insights into the stock's future performance.

Frequently Asked Questions

1. When is Tempus AI expected to announce its earnings?

Tempus AI will release its earnings for Q2 shortly, with speculation about a notable quarterly loss and impressive revenue growth.

2. What has contributed to the rise in Tempus AI's stock?

The stock has gained momentum due to analyst upgrades and a significant regulatory milestone regarding FDA clearance of their software.

3. How have analysts rated Tempus AI's stock?

Analysts maintain a mix of ratings, with several Buy recommendations and increased price targets reflecting confidence in the company's future.

4. What is the latest price target for Tempus AI's stock?

The price targets have been adjusted, with analysts suggesting targets ranging from $60 to $74 for the shares.

5. Why is FDA clearance important for Tempus AI?

The FDA clearance for their ejection fraction software marks a significant milestone, potentially boosting market confidence and positioning for Tempus AI.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.